Bill Summary

HB 351 Prescription Drug Pricing Transparency (2018 Session)
Prescription Drug Pricing Transparency: Requires pharmacists to inform customers of certain generically equivalent drug products & whether cost-sharing obligations to such customers exceed retail price of prescription; requires registration with OIR; provides registration requirements; requires registrant to report certain changes by specified date; requires office to issue registration certificate upon receipt of completed registration form; provides for expiration; requires rulemaking; requires certain terms in health insurer or health maintenance organization contracts with pharmacy benefit managers. Effective Date: July 1, 2018
10/16/17
HOUSE 
Filed
10/26/17
HOUSE 
Referred to Health Innovation Subcommittee; Appropriations Committee; Health & Human Services Committee
10/26/17
HOUSE 
Now in Health Innovation Subcommittee
01/12/18
HOUSE 
On Committee agenda - Health Innovation Subcommittee, 01/17/18, 12:30 pm, 306 H
01/17/18
HOUSE 
Favorable with CS by Health Innovation Subcommittee; 14 Yeas, 0 Nays
01/25/18
HOUSE 
Committee Substitute Text (C1) Filed
01/26/18
HOUSE 
Now in Appropriations Committee
02/02/18
HOUSE 
On Committee agenda - Appropriations Committee, 02/06/18, 3:00 pm, 212 K
02/06/18
HOUSE 
Favorable by Appropriations Committee; 26 Yeas, 0 Nays
02/07/18
HOUSE 
Now in Health & Human Services Committee
02/13/18
HOUSE 
On Committee agenda - Health & Human Services Committee; 02/15/18, 8:30 am, 17 H
02/15/18
HOUSE 
Favorable with CS by Health & Human Services Committee; 18 Yeas, 0 Nays
02/19/18
HOUSE 
Committee Substitute Text (C2) Filed
02/22/18
HOUSE 
Placed on Calendar, on 2nd reading
02/22/18
HOUSE 
Placed on Special Order Calendar, 02/28/18
02/28/18
HOUSE 
Read Second Time; Placed on Third Reading, 03/01/18
03/01/18
HOUSE 
Read Third Time; Passed (Vote: 115 Yeas / 0 Nays)
03/01/18
SENATE
In Messages
03/01/18
SENATE
Received; Referred to Health Policy; Banking and Insurance; Appropriations
03/07/18
SENATE
Withdrawn from Health Policy; Banking and Insurance; Appropriations; Placed on Calendar, on 2nd reading; Substituted for SBĀ 1494; Placed on Third Reading, 03/08/18
03/08/18
SENATE
Read Third Time; Passed (Vote: 37 Yeas / 0 Nays)
03/08/18
HOUSE 
Ordered enrolled
03/08/18
HOUSE 
Enrolled Text (ER) Filed
03/21/18
______ 
Signed by Officers and presented to Governor (Governor must act on this bill by 04/05/18)
03/23/18
______ 
Approved by Governor; Chapter No. 2018-091
05/01/18
______ 
Bill to be Discussed During the Office of EDR's Post-Session Estimating Impact Conference, 05/03/18, 9:00 am, 117 K (No Votes Will Be Taken)
0351
Filed on 10/16/17
PDF
Amendment 580305 DE
Filed on 01/16/18
Adopted
0351C1
Filed on 01/25/18
PDF
Amendment 480683 DE
Filed on 02/14/18
Adopted
0351C2
Filed on 02/19/18
PDF
No amendments to this bill text filed.
0351ER
Filed on 03/08/18
PDF
No amendments to this bill text filed.
465.0244
465.1862
624.49
627.64741
627.6572
641.314
Research & Reports
Revenue Estimating Coverence Reports, Veto, Transmittal letters and more. Learn more.

No reports related to this bill.

Upcoming Events
Florida's most comprehensive legislative calendar. Learn more.

No events are scheduled at this time.

Press Releases
Related Press Announcements. Learn more.
Features above are available to LobbyTools subscribers. Request a free demo or call (850) 915-0100 ext. 2 to learn more.